Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Aarti Pharmalabs Limited (NSE: AARTIPHARM), ISIN INE0LRU01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AARTIPHARM last traded at ₹920.30 (-0.95%), with a 52-week range of ₹585.00 to ₹1002.40 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 39.66%, FIIs 8.16%, DIIs 8.40%, mutual funds 0.60%.
EquiSense Score (ECS): 69/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.